Terns Pharma stockholders elect three Class I directors and ratify E&Y as auditor

Terns Pharmaceuticals, Inc.

Carl Gordon, Hongbo Lu, and Ann Taylor elected as Class I directors, each with majority votes.
Gordon received 18,623,269 votes for (2,386,359 withheld); Lu received 16,687,573 for (4,322,055 withheld).
Taylor received 20,998,888 votes for (10,740 withheld); broker non-votes of 1,626,573 on all director elections.
Ernst & Young ratified as auditor for FY2022 with 22,635,538 votes for, 363 against, 300 abstentions.
Meeting held June 16, 2022; record date April 22, 2022 with 25,269,271 shares entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.